Attached files
file | filename |
---|---|
EX-31.1 - EX-31.1 - EyePoint Pharmaceuticals, Inc. | d643405dex311.htm |
10-K/A - 10-K/A - EyePoint Pharmaceuticals, Inc. | d643405d10ka.htm |
Exhibit 31.2
Certification of Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended.
CERTIFICATIONS
I, David Price, certify that:
3. | I have reviewed this Amendment to the Annual Report on Form 10-K of EyePoint Pharmaceuticals, Inc. for the fiscal year ended June 30, 2018; |
4. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Date: October 29, 2018
/s/ David Price | ||
Name: | David Price | |
Title: | Chief Financial Officer | |
(Principal Financial Officer) |
48